1. Academic Validation
  2. Rational design of the first small-molecule antagonists of NHERF1/EBP50 PDZ domains

Rational design of the first small-molecule antagonists of NHERF1/EBP50 PDZ domains

  • Bioorg Med Chem Lett. 2008 Feb 1;18(3):942-5. doi: 10.1016/j.bmcl.2007.12.038.
Anand Mayasundari 1 Antonio M Ferreira Liwen He Neeraj Mahindroo Don Bashford Naoaki Fujii
Affiliations

Affiliation

  • 1 Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Abstract

This report describes the first small-molecule antagonists that specifically target the ligand-binding pocket of PDZ domains of NHERF1 multi-functional adaptor protein. Comparison of the peptide sequence homology between the native ligand of NHERF1 PDZ domains and an indole-based non-peptide chemical scaffold allowed the design of a small-molecule antagonist of NHERF1 PDZ domains.

Figures
Products